全文获取类型
收费全文 | 1557815篇 |
免费 | 109599篇 |
国内免费 | 3902篇 |
专业分类
耳鼻咽喉 | 22206篇 |
儿科学 | 46012篇 |
妇产科学 | 42713篇 |
基础医学 | 216095篇 |
口腔科学 | 43832篇 |
临床医学 | 135177篇 |
内科学 | 308692篇 |
皮肤病学 | 33238篇 |
神经病学 | 127866篇 |
特种医学 | 61037篇 |
外国民族医学 | 444篇 |
外科学 | 241830篇 |
综合类 | 34202篇 |
现状与发展 | 6篇 |
一般理论 | 735篇 |
预防医学 | 111362篇 |
眼科学 | 37245篇 |
药学 | 115203篇 |
10篇 | |
中国医学 | 3302篇 |
肿瘤学 | 90109篇 |
出版年
2019年 | 12653篇 |
2018年 | 17021篇 |
2017年 | 13500篇 |
2016年 | 14934篇 |
2015年 | 17041篇 |
2014年 | 24267篇 |
2013年 | 35693篇 |
2012年 | 48866篇 |
2011年 | 51500篇 |
2010年 | 30137篇 |
2009年 | 28548篇 |
2008年 | 48281篇 |
2007年 | 52025篇 |
2006年 | 52411篇 |
2005年 | 51198篇 |
2004年 | 49335篇 |
2003年 | 47266篇 |
2002年 | 45896篇 |
2001年 | 65476篇 |
2000年 | 66771篇 |
1999年 | 57412篇 |
1998年 | 17372篇 |
1997年 | 15701篇 |
1996年 | 14851篇 |
1995年 | 14021篇 |
1994年 | 12989篇 |
1992年 | 43867篇 |
1991年 | 42278篇 |
1990年 | 41415篇 |
1989年 | 40372篇 |
1988年 | 37800篇 |
1987年 | 37232篇 |
1986年 | 35724篇 |
1985年 | 33942篇 |
1984年 | 25868篇 |
1983年 | 22027篇 |
1982年 | 13856篇 |
1981年 | 12677篇 |
1979年 | 24531篇 |
1978年 | 17697篇 |
1977年 | 15379篇 |
1976年 | 13874篇 |
1975年 | 15653篇 |
1974年 | 18478篇 |
1973年 | 17897篇 |
1972年 | 17092篇 |
1971年 | 15943篇 |
1970年 | 15120篇 |
1969年 | 14490篇 |
1968年 | 13579篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文
5.
6.
7.
8.
Krishna Pillai Javid Akhter Terence C. Chua Mena Shehata Nayef Alzahrani Issan Al-Alem David L. Morris 《Medicine》2015,94(9)
Thermal ablation of liver tumors near large blood vessels is affected by the cooling effect of blood flow, leading to incomplete ablation. Hence, we conducted a comparative investigation of heat sink effect in monopolar (MP) and bipolar (BP) radiofrequency ablation (RFA), and microwave (MW) ablation devices.With a perfused calf liver, the ablative performances (volume, mass, density, dimensions), with and without heat sink, were measured. Heat sink was present when the ablative tip of the probes were 8.0 mm close to a major hepatic vein and absent when >30 mm away. Temperatures (T1 and T2) on either side of the hepatic vein near the tip of the probes, heating probe temperature (T3), outlet perfusate temperature (T4), and ablation time were monitored.With or without heat sink, BP radiofrequency ablated a larger volume and mass, compared with MP RFA or MW ablation, with latter device producing the highest density of tissue ablated. MW ablation produced an ellipsoidal shape while radiofrequency devices produced spheres.Percentage heat sink effect in Bipolar radiofrequency : Mono-polar radiofrequency : Microwave was (Volume) 33:41:22; (mass) 23:56:34; (density) 9.0:26:18; and (relative elipscity) 5.8:12.9:1.3, indicating that BP and MW devices were less affected.Percentage heat sink effect on time (minutes) to reach maximum temperature (W) = 13.28:9.2:29.8; time at maximum temperature (X) is 87:66:16.66; temperature difference (Y) between the thermal probes (T3) and the temperature (T1 + T2)/2 on either side of the hepatic vessel was 100:87:20; and temperature difference between the (T1 + T2)/2 and temperature of outlet circulating solution (T4), Z was 20.33:30.23:37.5.MW and BP radiofrequencies were less affected by heat sink while MP RFA was the most affected. With a single ablation, BP radiofrequency ablated a larger volume and mass regardless of heat sink. 相似文献
9.
10.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献